- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00541879
Obesity and Diabetes Prevention Through Science Enrichment (DKENERGY)
November 5, 2014 updated by: Colorado State University
Type 2 Diabetes Knowledge: Obesity and Diabetes Prevention Through Science Enrichment
Type 2 diabetes and obesity in children continue to increase at alarming rates with devastating results.
However, both these metabolic diseases are largely preventable through adoption of a healthy lifestyle, an understanding of what happens to food in the body, energy balance and some simple aspects of glucose regulation.
Can elementary school children be taught the knowledge and skills necessary to prevent type 2 diabetes and obesity?
Children need to learn this essential knowledge and practice these important health behavior skills.
Elementary school may be an ideal place to master this subject that is a direct and logical extension of current health curricula including nutrition and physical activity blended with science and math.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Biomedical scientists lead a classroom series of interactive, inquiry-based science and health explorations directed at type 2 diabetes, obesity and their prevention in three elementary schools serving children at high risk for type 2 diabetes.
Diabetes knowledge was measured in children and parents at the beginning, end and 9 months after the end of the intervention using validated questionnaires.
Study Type
Interventional
Enrollment (Actual)
2909
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Fort Collins, Colorado, United States, 80524
- Putnam, Tavelli, Bennett and Dunn Elementary Schools
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 13 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Elementary school child in selected intervention or comparison classes/schools
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: I
Elementary school children -grades 2-6 participating in Program ENERGY
|
Weekly or biweekly classroom and gym based science enrichment focused on how the body works including blood glucose regulation, healthy eating and physical activity, diabetes abd how it can be prevented
|
|
Sham Comparator: II
Elementary school children in grades 2-6 matched to the intervention classes not receiving any intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Diabetes knowledge and prevention behaviors in elementary school children
Time Frame: one-three school year(s)
|
one-three school year(s)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Parental diabetes knowledge, self-reported physical activity
Time Frame: one -three school year(s)
|
one -three school year(s)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: L. Arthur Campfield, PhD, Colorado State University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2001
Primary Completion (Actual)
September 1, 2011
Study Completion (Actual)
September 1, 2011
Study Registration Dates
First Submitted
October 9, 2007
First Submitted That Met QC Criteria
October 9, 2007
First Posted (Estimate)
October 10, 2007
Study Record Updates
Last Update Posted (Estimate)
November 7, 2014
Last Update Submitted That Met QC Criteria
November 5, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H 04-257 RR25 RR 020469
- R 25 RR 020469
- R 25 RR 015646
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.